📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! Tell us what works, what doesn't, and how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community. Please send your feedback to gateway@ukri.org by 11 August 2025.

Pleotropic effects of a recessive C OL1a2 mutation occurring in a mouse model of severe osteogenesis imperfecta (2024)

First Author: Corcelli M

Attributed to: Combining iPSC and gene editing with cell therapy to develop the next generation of MSC-based therapeutics to counteract bone fragility in OI. funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1101/2024.02.15.580510

Publication URI: http://dx.doi.org/10.1101/2024.02.15.580510

Type: Preprint